Hand Sanitizer

Ethyl Alcohol


Zhejiang Jinghui Cosmetics Share Co.,ltd
Human Otc Drug
NDC 73905-003
Hand Sanitizer also known as Ethyl Alcohol is a human otc drug labeled by 'Zhejiang Jinghui Cosmetics Share Co.,ltd'. National Drug Code (NDC) number for Hand Sanitizer is 73905-003. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Hand Sanitizer drug includes Alcohol - 70 mL/100mL . The currest status of Hand Sanitizer drug is Active.

Drug Information:

Drug NDC: 73905-003
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Hand Sanitizer
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Ethyl Alcohol
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Zhejiang Jinghui Cosmetics Share Co.,ltd
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ALCOHOL - 70 mL/100mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH NOT FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 28 Mar, 2020
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 09 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part333A
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:ZHEJIANG JINGHUI COSMETICS SHARE CO.,LTD
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:582753
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:6944348522890
6944348524436
UPC stands for Universal Product Code.
UNII:3K9958V90M
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
73905-003-01100 mL in 1 BOTTLE (73905-003-01)28 Mar, 2020N/ANo
73905-003-0220 mL in 1 BOTTLE (73905-003-02)28 Mar, 2020N/ANo
73905-003-0330 mL in 1 BOTTLE (73905-003-03)28 Mar, 2020N/ANo
73905-003-0455 mL in 1 BOTTLE (73905-003-04)28 Mar, 2020N/ANo
73905-003-0560 mL in 1 BOTTLE (73905-003-05)28 Mar, 2020N/ANo
73905-003-0680 mL in 1 BOTTLE (73905-003-06)28 Mar, 2020N/ANo
73905-003-07120 mL in 1 BOTTLE (73905-003-07)28 Mar, 2020N/ANo
73905-003-08200 mL in 1 BOTTLE (73905-003-08)28 Mar, 2020N/ANo
73905-003-09236 mL in 1 BOTTLE (73905-003-09)28 Mar, 2020N/ANo
73905-003-10260 mL in 1 BOTTLE (73905-003-10)28 Mar, 2020N/ANo
73905-003-11300 mL in 1 BOTTLE (73905-003-11)28 Mar, 2020N/ANo
73905-003-12500 mL in 1 BOTTLE (73905-003-12)28 Mar, 2020N/ANo
73905-003-13560 mL in 1 BOTTLE (73905-003-13)28 Mar, 2020N/ANo
73905-003-14980 mL in 1 BOTTLE (73905-003-14)28 Mar, 2020N/ANo
73905-003-15985 mL in 1 BOTTLE (73905-003-15)28 Mar, 2020N/ANo
73905-003-162000 mL in 1 BOTTLE (73905-003-16)28 Mar, 2020N/ANo
73905-003-173000 mL in 1 BOTTLE (73905-003-17)28 Mar, 2020N/ANo
73905-003-184000 mL in 1 BOTTLE (73905-003-18)28 Mar, 2020N/ANo
73905-003-195000 mL in 1 BOTTLE (73905-003-19)28 Mar, 2020N/ANo
73905-003-2020000 mL in 1 BOTTLE (73905-003-20)28 Mar, 2020N/ANo
73905-003-2125000 mL in 1 BOTTLE (73905-003-21)28 Mar, 2020N/ANo
73905-003-2250000 mL in 1 BOTTLE (73905-003-22)28 Mar, 2020N/ANo
73905-003-23200000 mL in 1 BOTTLE (73905-003-23)28 Mar, 2020N/ANo
73905-003-241000000 mL in 1 BOTTLE (73905-003-24)28 Mar, 2020N/ANo
73905-003-25750 mL in 1 BOTTLE (73905-003-25)28 Mar, 2020N/ANo
73905-003-2610 mL in 1 BOTTLE (73905-003-26)28 Mar, 2020N/ANo
73905-003-2745 mL in 1 BOTTLE (73905-003-27)28 Mar, 2020N/ANo
73905-003-28180 mL in 1 BOTTLE (73905-003-28)28 Mar, 2020N/AYes
73905-003-29240 mL in 1 BOTTLE (73905-003-29)28 Mar, 2020N/ANo
73905-003-30250 mL in 1 BOTTLE (73905-003-30)28 Mar, 2020N/ANo
73905-003-31350 mL in 1 BOTTLE (73905-003-31)28 Mar, 2020N/ANo
73905-003-32400 mL in 1 BOTTLE (73905-003-32)28 Mar, 2020N/ANo
73905-003-33600 mL in 1 BOTTLE (73905-003-33)28 Mar, 2020N/ANo
73905-003-34900 mL in 1 BOTTLE (73905-003-34)28 Mar, 2020N/ANo
73905-003-351000 mL in 1 BOTTLE (73905-003-35)28 Mar, 2020N/ANo
73905-003-361500 mL in 1 BOTTLE (73905-003-36)28 Mar, 2020N/ANo
73905-003-372500 mL in 1 BOTTLE (73905-003-37)28 Mar, 2020N/ANo
73905-003-3810000 mL in 1 BOTTLE (73905-003-38)28 Mar, 2020N/ANo
73905-003-3945000 mL in 1 BOTTLE (73905-003-39)28 Mar, 2020N/ANo
73905-003-40100000 mL in 1 BOTTLE (73905-003-40)28 Mar, 2020N/ANo
73905-003-41500000 mL in 1 BOTTLE (73905-003-41)28 Mar, 2020N/ANo
73905-003-42237 mL in 1 BOTTLE (73905-003-42)28 Mar, 2020N/ANo
73905-003-433800 mL in 1 BOTTLE (73905-003-43)28 Mar, 2020N/ANo
73905-003-442 mL in 1 BAG (73905-003-44)28 Mar, 2020N/ANo
73905-003-451.2 mL in 1 BAG (73905-003-45)28 Mar, 2020N/ANo
73905-003-465 mL in 1 BAG (73905-003-46)28 Mar, 2020N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose antiseptic

Product Elements:

Hand sanitizer ethyl alcohol water carbomer homopolymer, unspecified type aminomethylpropanol glycerin propylene glycol alcohol alcohol

Indications and Usage:

Use to decrease bacteria on the skin that could cause disease recommended for repeated use

Warnings:

Warnings for external use only flammable keep away from fire or flame

Do Not Use:

Warnings for external use only flammable keep away from fire or flame

When Using:

Keep out of eyes.in case of contact with eyes,flush thoroughly with water. avoid contact with broken skin do not inhale or ingest

Dosage and Administration:

Directions place enough product on hands to cover all surfaces.rub hands together until dry. supervise children under 6 years of age when using this product to avoid swallowing.

Stop Use:

Irritation or redness develops condition persists for more than 72 hours

Package Label Principal Display Panel:

Hand sanitizer 180ml example, same to the others hand sanitizer 2ml example, same to 1.2ml and 5ml 180ml ndc: 73905-003-28 2ml ndc: 73905-003-47 180 2ml


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.